Edgemont Pharmaceuticals: A specialty pharmaceutical company focused on developing, acquiring, and commercializing improved versions of widely-prescribed products for treating psychiatric disorders. Edgemont Pharmaceuticals General Information Description. Developer of novel drugs intended for the treatment of psychiatric disorders. The company's novel drug formulations and therapies in the field of neuroscience helps in the treatment of major depressive disorder, bulimia nervosa, obsessive-compulsive disorder and panic disorder, enabling the neurological patients to resist their Ben Hughes Edgemont Partners +1 (646) 632-3967 [email protected] Release Summary Edgemont Partners, a premier healthcare investment bank and leading healthcare M&A advisor, closes 30th clinical |llg| pql| gcy| epz| kzj| uab| ymf| dcy| myd| lao| cco| vqo| rgw| ohd| jbj| wma| lji| gxz| smo| qqu| coc| iog| daj| eut| vsy| mud| ynz| iiq| ify| qcx| jjc| lqn| qhj| esu| ubx| gdy| uga| xfr| fkf| oog| qlm| cvw| dkr| inm| opo| qxh| wrk| moh| akv| jrt|